The RDTC has updated the COVID-19 QAAs No.4 (Monitoring direct acting oral anticoagulants) with more detail on monitoring and the recent
The latest NCSO bulletin based on October 2020 prices is now available online for stakeholders only.
Our Cost Comparison Charts have been updated for October 2020.
August 2020 reports are now online. These documents are available to our stakeholders only (username and password required).
A new RDTC stakeholder publication “Prescribing for Population Health” is now available.
The New Drug Evaluation for oral semaglutide (Rybelsus) for the treatment of type 2 diabetes mellitus is now available to stakeholders.
Updates to our Items not to be routinely prescribed (INRP) report with 20202021 Q1 data are now available online.
The antibacterial drugs report for April to June 2020 is now available.
The New Drug Evaluation for Brolucizumab for the treatment of wet age-related macular degeneration is now available to stakeholders.